The Fortune Business Insights adds Global "C-Reactive Protein Testing Market" 2023-2030 report that offers an total content of the assiduity with brief analysis, data maps, numbers, statistics that help take business opinions, company biographies and further.

The Complete report specifies the historical, present, and projected size of the market from the standpoint of both value and volume. SWOT and Value Chain Analysis are utilized to gauge the market. The market is very fragmented by type and application, with sales market share and rate of growth by type, application.

Also report compromises in-depth analysis covering key regional trends, market dynamics, and provides country-level market size of the worldwide C-Reactive Protein Testing Market.

Get a Free Sample Research PDF :

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/107164

About C-Reactive Protein Testing Market Growth and Size

In November 2022, ProciseDx Inc. announced FDA clearance of its ProciseDx instrument and CRP test. Procise CRP gives a quantitative determination of CRP levels in patient serum in less than 5 minutes. ProciseDx expects FDA clearances of additional tests in 2023. In January 2022, LumiraDx announced its C-reactive protein (CRP) Test had achieved CE Marking. The LumiraDx CRP Test is a small, portable, fully automated, microfluidic immunoassay test used to determine C-reactive protein with results within four minutes quantitatively.

The global C-Reactive Protein Testing Market was valued at USD million in 2022 and is anticipated to reach USD million by 2029, witnessing a CAGR of during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American C-Reactive Protein Testing Market is estimated to increase from USD million in 2023 to reach USD million by 2029, at a CAGR of during the forecast period of 2023 through 2029.

Asia-Pacific C-Reactive Protein Testing Market is estimated to increase from USD million in 2023 to reach USD million by 2029, at a CAGR of during the forecast period of 2023 through 2029.

C-Reactive Protein Testing Market Research is spread across 100+ pages and provides exclusive data, information, vital statistics, trends and competitive landscape details in this niche sector.

Major Players in C-Reactive Protein Testing Market 2023 are:

The report will include the profiles of key players such as Laboratory Corporation of America Holdings, Abaxis, Inc., Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Merck KGaA, Quest Diagnostics Incorporated, Randox Laboratories Ltd., Siemens Healthineers, Getein Biotech, Inc. and others.

For More Information :

https://www.fortunebusinessinsights.com/c-reactive-protein-testing-market-107164

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd

U.S.: +1 424 253 0390

U.K.: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com